USANA
July 26, 2022
USANA Health Sciences said second-quarter 2022 net sales were 264.5 million dollars, down 21 percent from a year earlier, or 18 percent in constant currency. Diluted earnings per share were 1.00 dollar versus 1.87 dollars a year earlier. Net earnings were 19.2 million dollars. Active customers fell 14 percent to 559,000.
Asia Pacific sales were 217.4 million dollars, down 22 percent, while Americas and Europe sales were 47.1 million dollars, down 19 percent. Chief executive and chairman Kevin Guest pointed to COVID disruptions in mainland China and a difficult year-ago comparison. The company reiterated fiscal 2022 guidance of 1.015 billion to 1.065 billion dollars in net sales and 3.85 to 4.45 dollars in diluted EPS, the outlook updated on July 6. Cash ended the quarter at 230 million dollars with no share repurchases in the period.